{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:42:22Z","timestamp":1793065342314,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.contraception.2012.07.008","type":"journal-article","created":{"date-parts":[[2012,9,16]],"date-time":"2012-09-16T23:48:06Z","timestamp":1347839286000},"page":"227-234","source":"Crossref","is-referenced-by-count":19,"title":["Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study"],"prefix":"10.1016","volume":"87","author":[{"given":"Jan","family":"Endrikat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Parke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Trummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Serrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Duijkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Klipping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.07.008_bb0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0010-7824(96)00201-6","article-title":"The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17 beta-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days","volume":"54","author":"Csemiczky","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.07.008_bb0010","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3109\/00016348709015732","article-title":"Ovulation inhibition with 17 beta-estradiol cyclo-octyl acetate and desogestrel","volume":"66","author":"Schubert","year":"1987","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2012.07.008_bb0015","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0140-6736(79)91525-3","article-title":"Natural oestrogens for oral contraception","volume":"2","author":"Serup","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.07.008_bb0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0010-7824(97)00123-6","article-title":"Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest","volume":"56","author":"Spona","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.07.008_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejogrb.2009.11.001","article-title":"Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate\/dienogest): a phase III trial","volume":"149","author":"Palacios","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2012.07.008_bb0030","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0002-9378(99)70120-1","article-title":"The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices","volume":"181","author":"Rivera","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.07.008_bb0035","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.contraception.2008.05.004","article-title":"Ovulation inhibition with four variations of a four-phasic estradiol valerate\/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies","volume":"78","author":"Endrikat","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.07.008_bb0040","author":"Bayer"},{"key":"10.1016\/j.contraception.2012.07.008_bb0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0301-2115(00)00267-0","article-title":"Ultrasonographic assessment of endocervix and cervical mucus in ovulatory menstrual cycles","volume":"93","author":"Duijkers","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2012.07.008_bb0050","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.fertnstert.2009.01.077","article-title":"Cervical mucus status can be accurately estimated by transvaginal ultrasound during fertility evaluation","volume":"92","author":"Wolman","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.07.008_bb0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/13625180902850039","article-title":"Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest","volume":"14","author":"Zeun","year":"2009","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.07.008_bb0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0029-7844(99)00524-4","article-title":"Hormone withdrawal symptoms in oral contraceptive users","volume":"95","author":"Sulak","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.07.008_bb0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2008.02.019","article-title":"Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24\/4 regimen","volume":"78","author":"Klipping","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.07.008_bb0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0010-7824(96)00137-0","article-title":"Shorter pill-free interval in combined oral contraceptives decreases follicular development","volume":"54","author":"Spona","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.07.008_bb0075","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3109\/13625187.2010.504313","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17 beta-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol","volume":"15","author":"Duijkers","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.07.008_bb0080","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.fertnstert.2005.06.044","article-title":"Oral contraceptives maintain a very thin endometrium before operative hysteroscopy","volume":"85","author":"Grow","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.07.008_bb0085","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0015-0282(01)01834-9","article-title":"Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 microg of ethinyl estradiol on the human endometrium","volume":"76","author":"Ludicke","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.07.008_bb0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/13625189709049933","article-title":"The effects of monophasic and triphasic oral contraceptives on ovarian function and endometrial thickness","volume":"2","author":"Rabe","year":"1997","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.07.008_bb0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/13625180701619247","article-title":"Contraceptive efficacy and safety of a low-dose oral contraceptive, (0.03 mg ethinyl oestradiol and 2 mg chlormadinone acetate) Belara, over three medication cycles","volume":"13","author":"Spona","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.07.008_bb0100","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.fertnstert.2009.06.057","article-title":"Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24\/4-day intake regimen over three cycles","volume":"94","author":"Spona","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.07.008_bb0105","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/humrep\/deg461","article-title":"The effect of endometrial thickness on IVF\/ICSI outcome","volume":"18","author":"Kovacs","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.07.008_bb0110","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/oxfordjournals.humrep.a138509","article-title":"Endometrial thickness: a predictor of implantation in ovum recipients?","volume":"9","author":"Abdalla","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.07.008_bb0115","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0015-0282(00)01695-2","article-title":"Endometrial receptivity in an in vitro fertilization program as assessed by spiral artery blood flow, endometrial thickness, endometrial volume, and uterine artery blood flow","volume":"75","author":"Schild","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.07.008_bb0120","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1469-0705.2001.00502.x","article-title":"Changes in endometrial thickness, width, length and pattern in predicting pregnancy outcome during ovarian stimulation in in vitro fertilization","volume":"18","author":"Bassil","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.07.008_bb0125","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/humrep\/16.11.2278","article-title":"The relationship between cervical secretions and the daily probabilities of pregnancy: effectiveness of the TwoDay Algorithm","volume":"16","author":"Dunson","year":"2001","journal-title":"Hum Reprod"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412006749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412006749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T13:56:36Z","timestamp":1542722196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412006749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0010782412006749"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.07.008","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}